SCHEMBL29673243

SCHEMBL29673243

CCC1(CC)CC(=O)c2cc(Br)ccc2O1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.47
PBRM1 Q86U86 1/20 0.47
KDM4E B2RXH2 8/20 0.41
ATM Q13315 3/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
AKT1 P31749 1/20 0.40
MAOB P27338 2/20 0.39
RAD52 P43351 1/20 0.39
ALDH1A1 P00352 4/20 0.39
GAA P10253 3/20 0.39
HPGD P15428 2/20 0.39
CASP1 P29466 2/20 0.39
HSD17B10 Q99714 2/20 0.39
GLA P06280 2/20 0.39
CASP7 P55210 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20587128 1.00 MAPT (0.47) MAPTPBRM1KDM4EATMHTT
SCHEMBL1977431 0.85 MAPT (0.43) MAPTPBRM1KDM4EATMHTT
SCHEMBL8539965 0.84 MAPT (0.43) MAPTPBRM1KDM4EATMHTT
SCHEMBL7466569 0.83 KDM4E (0.60) MAPTKDM4EATMHTTKMT2A
SCHEMBL6599913 0.82 MAPT (0.41) MAPTPBRM1KDM4EATMHTT
SCHEMBL3322611 0.82 MAPT (0.43) MAPTKDM4EATMHTTKMT2A
SCHEMBL1821389 0.80 MAPT (0.71) MAPTPBRM1KDM4EATMHTT
SCHEMBL25857504 0.79 MAPT (0.41) MAPTKDM4EATMHTTKMT2A
SCHEMBL20587543 0.79 KDM4E (0.45) MAPTKDM4EATMHTTKMT2A
SCHEMBL31513297 0.79 KDM4E (0.45) MAPTKDM4EATMHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114585360-B Methods of using the same for treating epilepsy 特维娜有限公司 2025-04-29 CN disclosed
CN-114585360-A Methods of using the same for the treatment of epilepsy 特维娜有限公司 2022-06-03 CN disclosed